Cic edizioni internazionali
Clinical Dermatology

Cyclosporine in the era of biologics: a mini-review with special emphasis on the possible use in combination with biologics for psoriasis

Review article, 15 - 18
Tag this article
Abstract
Enhanced HTML Full text PDF
Combination of systemic biological and traditional agents is increasingly used for the treatment of “highneed” patients with psoriasis. There are only limited data on the combination of cyclosporine with biological drugs for the treatment of psoriatic disease. This article briefly reviews the available information on this combination strategy.

Vol. 7 (No. 2) 2019 April - June

  1. A case report of atypical presentation of pyoderma gangrenosum with ulcerative colitis: successful treatment with prednisolone and mesalazine therapy
    Abou-Taleb D. A.E, F. Sherif M., Mohammed A.S.
  2. Histopathological coexistence of extragenital lichen sclerosus and morphea in a single lesion: a case report
    Almuqati R., Hariri J., Abduljabbar M.
  3. Hedgehog pathway inhibitors for basal cell carcinoma: case reports and review of the literature
    Singer C., O’Sullivan N.-A., Vinciullo C.
  4. Sirolimus therapy for refractory kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: a case report
    Valsassina R., Contreiras M., Strecht J., Melo F., Oom P.
  5. Superimposed Mongolian spot and mucopolysaccharidosis VI
    Ribeiro E.M., Ribeiro Fontenele Bezerra K., César Cardoso-dos-Santos A., Lourenço C.M., Kiszewski A.E.
  6. First reported case of primary peritoneal malignancy with initial presentation as cutaneous metastases
    Wong V., Tharakaram S., Kontogiorgi D., Shahzad J., Burova E., Maidment G., Smith S., Vohra V.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Cyclosporine in the era of biologics: a mini-review with special emphasis on the possible use in combination with biologics for psoriasis
    Cassano N., Vena G.A.
credits